Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

Hearing About Breakthroughs Made in Hematologic Malignancies in Boston

Published: Wednesday, Jun 26, 2019

We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from the faculty from Dana-Farber Cancer Institute. The meeting covered frontline approaches and sequencing challenges in multiple myeloma, key advances in mantle cell lymphoma, and novel agents in chronic lymphocytic leukemia. Experts also highlighted progress made with CAR T-cell therapy in pediatric acute lymphoblastic leukemia, TKI discontinuation in patients with chronic myeloid leukemia, options for benign hematologic disorders, and headway made in acute myeloid leukemia.
View Conference Coverage
Online CME Activities
Publication Bottom Border
Border Publication